抗骨誘導因子(OGN)多克隆抗體
Anti-Osteoglycin (OGN) Polyclonal Antibody
OIF; SLRR3A; Mimecan Proteoglycan; Osteoinductive Factor
- 編號FAC688Ra01
- 物種Rattus norvegicus (Rat,大鼠)相同的名稱,不同的物種。
- 效價-
- Ig類型IgG
- 純化方式抗原特異性親和純化
- 標記物無標記物
- 激發(fā)波長
- 單次使用量
- 緩沖液成份磷酸鹽緩沖液(pH7.4,含有0.02% NaN3和50%甘油)
- 性狀液體
- 且適物種Homo sapiens (Human,人)
- 應用FCM
- 下載英文說明書 中文說明書
- 規(guī)格25test50test100test200test500test
- 價格暫無報價暫無報價暫無報價暫無報價暫無報價
- 欲了解實際交易價格和更多情況,請與當?shù)亟?jīng)銷商聯(lián)系!
用法
Flow cytometry: 20μg/ml;
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過一年。避免反復凍融。
贈品
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種:Rattus norvegicus (Rat,大鼠) | 應用(僅供研究使用,不用于臨床診斷!) |
| RPC688Ra01 | 骨誘導因子(OGN)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAC688Ra01 | 骨誘導因子(OGN)多克隆抗體 | WB |
| FAC688Ra01 | 抗骨誘導因子(OGN)多克隆抗體 | FCM |
| LAC688Ra71 | 骨誘導因子(OGN)多克隆抗體(生物素標記) | WB |
參考文獻
| 雜志 | 參考文獻 |
| Bone. | Association of osteoglycin and FAM5C with bone turnover markers, bone mineral density, and vertebral fractures in postmenopausal women with type 2 diabetes mellitus.[pubmed:27836731] |
| Tohoku journal of experimental medicine | Higher Serum Levels of Osteoglycin Are Associated with All-Cause Mortality and Cardiovascular and Cerebrovascular Events in Patients with Advanced Chronic Kidney Disease.[pubmed:28824047] |
| Molecular Metabolism | Osteoglycin, a novel coordinator of bone and glucose homeostasis[Pubmed:29799418] |
| Journal of Experimental &?Clinical?Cancer?Research | Osteoglycin (OGN) reverses epithelial to mesenchymal transition and invasiveness in colorectal cancer via EGFR/Akt pathway[Pubmed:29499765] |
| Journal of Human Hypertension | Association of SLRPs with carotid artery atherosclerosis in essential hypertensive patients[Pubmed:29867136] |
| Cell?Reports | Transforming Growth Factor-β3 Regulates Adipocyte Number in Subcutaneous White Adipose Tissue[Pubmed: 30332637] |
| J Clin Endocrinol Metab | Osteoglycin across the adult lifespan[34850904] |



